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[Abstract] An immune response can be activated by pathogenic stimuli, as well as endogenous danger 
signals, triggering the activation of pattern recognition receptors and initiating signalling cascades that 
lead to inflammation. This method uses THP1-BlueTM cells, a human monocytic cell line which contains 
an embryonic alkaline phosphatase reporter gene allowing the detection of NF-κB-induced 
transcriptional activation. We validated this protocol by assessing NF-κB activation after stimulation of 
toll-like receptor 4 (TLR4) by two different agonists: lipopolysaccharide (LPS), derived from the cell wall 
of Gram negative bacteria, and tenascin-C, an extracellular matrix protein whose expression is induced 
upon tissue injury. We then used this protocol to screen for potential new endogenous TLR4 agonists, 
but this method can also be used as a quick, economical and reliable means to assay the activity of 
other inflammatory stimuli resulting in TLR-dependent NF-κB activation.  
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[Background] The immune system has evolved to recognize not only pathogenic stimuli such as 
bacterial components and viral nucleic acids, but also endogenous danger signals including proteins 
secreted from necrotic cells or expressed upon tissue damage. Both types of stimuli are sensed by 
pattern recognition receptors, initiating signalling cascades that trigger inflammatory responses. Nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-κB) is a transcription factor essential for the 
activation of the immune response to infection and tissue damage. NF-κB has an important role in the 
expression of a wide range of inflammatory mediators following pattern recognition receptor activation, 
including cytokines (such as tumour necrosis factor α [TNFα], interleukin-6 and interleukin-1), 
chemokines (e.g., interleukin-8 or CXCL1), proteases, growth factors and MHC-related molecules, 
among others. To assess the activation of this pathway downstream of TLR4, we used the commercially 
available cell line THP1-BlueTM NF-κB (Invivogen). These cells are stably transfected with a construct 
containing a secreted embryonic alkaline phosphatase (SEAP) gene induced by the NF-κB transcription 
factor. The construct contains an interferon-β minimal promoter fused to five copies of the NF-κB 
consensus transcriptional response element and three copies of the c-Rel binding site, which drives the 
expression of the reporter gene. After cell stimulation with pathogenic or endogenous stimuli, NF-κB 
activation leads to the secretion of SEAP, which is then quantified using the colorimetric reagent 
QUANTI-BlueTM. This is a quick and reliable method to assess activation of NF-κB downstream of toll-
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like receptors, as the amount of SEAP in the media correlates with the triggering of this signalling 
pathway. However, this is an engineered cell line that does not express a full complement of 
inflammatory effector molecules (see Note 5), and so whilst useful in screening for NF-κB activation, 
data should always be confirmed in additional experimental systems, for example in primary 
macrophages, or in vivo. 
 
Materials and Reagents 
 
1. Pipette tips  
20 µl (StarLabs, TipOne®, catalog number: S1110-3800) 
200 µl (StarLabs, TipOne®, catalog number: S1111-0806) 
1,000 µl (StarLabs, TipOne®, catalog number: S1111-6801) 
2. Corning 15 ml PP centrifuge sterile tubes (Corning, catalog number: 430791) 
3. Cell culture flask 75 cm2 (VWR, catalog number: 734-0012) 
4. 96 well plate flat-bottom (VWR, catalog number: 734-0023) 
5. THP1-BlueTM NF-κB cells (InvivoGen, catalog number: thp-nfkb) 
6. Positive control: LPS from E. coli, Serotype EH100 (Ra) (TLRgradeTM) (Enzo life sciences, 
catalog number: ALX-581-010-L002) 
7. Test inflammatory stimulus: for example recombinant tenascin-C protein or the fibrinogen like 
globe domain (FBG) of tenascin-C protein (synthesized as described in Midwood et al., 2009) 
8. Roswell Park Memorial Institute (RPMI) 1640 with L-glutamine (Lonza, catalog number: BE12-
702F) 
9. Fetal bovine serum (FBS), Qualified, heat inactivated (Thermo Fisher Scientific, GibcoTM, 
catalog number: 10500064) 
10. Penicillin/streptomycin (Thermo Fisher Scientific, GibcoTM, catalog number: 15140122) 
11. NormocinTM (InvivoGen, catalog number: ant-nr-1)  
12. Blasticidin HCl (Thermo Fisher Scientific, GibcoTM, catalog number: R21001) 
13. QUANTI-BlueTM (InvivoGen, catalog number: rep-qb1) 
14. ThP1 media without blasticidin (see Recipes) 
15. ThP1 media with blasticidin (see Recipes) 
16. QUANTI-BlueTM solution (see Recipes) 
 
Equipment 
 
1. P20, P200 and P1000 pipettes 
2. 37 °C water bath 
3. Hemocytometer  
4. CO2 incubator 
5. FluoStar Omega plate reader  
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6. Centrifuge (Thermo Fisher Scientific, model: HeraeusTM MAgefugeTM 16)  
7. Rotor (Thermo Fisher Scientific, Thermo ScientificTM, model: TX-400 4 x 400 mL Swinging 
Bucket Rotor, catalog number: 75003629) 
 
Software 
 
1. Graph Pad Prism  
 
Procedure 
 
A. Cell culture conditions 
1. Thaw a vial containing 3-7 x 106 THP1-BlueTM NF-κB cells in a 37 °C water bath. 
2. Transfer cells to a 15 ml sterile tube containing 10 ml of pre-warmed ThP1 NF-κB medium 
without blasticidin (see Recipes). Centrifuge tube at 320 x g for 5 min. 
3. Remove supernatant and resuspend cells in 10 ml of ThP1 NF-κB medium without blasticidin. 
Count the cells using a hemocytometer.  
4. Transfers 1 x 106 cells in 10 ml of ThP1 NF-κB medium without blasticidin to a 75 cm2 cell culture 
flask and place the culture at 37 °C in 5% CO2. 
5. The cells grow in suspension. To passage the cells, transfer cells to a sterile 15 ml tube and 
measure cell concentration using a hemocytometer. Centrifuge tube at 320 x g for 5 min at room 
temperature, remove cell supernatant and resuspend cells in fresh media. Passage the cells 
every 3 days and do not let the cell concentration in the flask exceed 2 x 106 cells/ml. 
6. For the first two passages, cells should be cultured in medium without blasticidin to allow 
recovery from freezing. After the second passage, culture the cells in ThP1 NF-κB medium with 
blasticidin (see Recipes) to maintain selection pressure. 
 
B. Cell stimulation 
1. Transfer cells to a 15 ml sterile tube. Centrifuge cells at 320 x g for 5 min. Remove supernatant 
and resuspend cells in new ThP1 NF-κB medium with blasticidin. 
2. Plate 1 x 105 cells per well in a flat-bottom 96 well plate in a final volume of 100 µl.  
3. Immediately after plating, stimulate cells by adding LPS or recombinant protein (e.g., FBG) 
diluted in 100 µl of media in duplicate or triplicate wells. The final volume in each well is 200 µl. 
4. Incubate the cells for 24 h at 37 °C in 5% CO2 (see Note 3). 
5. To measure NF-κB-induced secreted alkaline phosphatase, collect cell supernatant. 
6. At this stage cells can be taken for assessment of viability for example by MTT assay. 
 
C. Measurement of NF-κB activation 
1. Warm QUANTI-BlueTM solution (see Recipes) at 37 °C for 10 min. 
2. Add 180 µl of QUANTI-BlueTM per well to a flat-bottom 96 well plate.  
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3. Add 20 µl of THP1-BlueTM cell supernatant to each well. 
4. Incubate the plate at 37 °C for 2 h. The media will change color from pink to blue in the presence 
of secreted embryonic alkaline phosphatase (Figure 1). 
5. Determine SEAP levels by reading the optical density (OD) at 620 nm using a 
spectrophotometer plate reader. 
 
 
Figure 1. Detection of secreted embryonic alkaline phosphatase using QUANTI-BlueTM. 
Activation of THP1-BlueTM NF-κB cells with decreasing doses of LPS plus negative control (NC) 
performed in duplicates. In the presence of SEAP the QUANTI-BlueTM media changes color 
from pink to blue. The blue color intensity correlates with NF-κB activation at different doses.  
 
Data analysis 
 
For each stimulus, plot the mean of OD values ± standard error of the mean (SEM), in the case of 
multiple independent experiments (Figure 2), or the mean of OD values ± standard deviation (SD), 
in the case of single experiments. The data can also be represented as fold change difference 
compared to non-stimulated cells. Perform statistical analysis using Graph Pad Prism or other 
software. 
 
  
Figure 2. NF-κB activation by LPS or the FBG domain of tenascin-C (FBG-C) in THP1-
BlueTM NF-κB cells. Cells were stimulated with different doses of LPS or FBG-C or left 
unstimulated (-) and after 24 h NF-κB activation was measured using QUANTI-BlueTM. Data 
shown as mean ± SEM, N = 3 independent experiments. One-way ANOVA vs. non-stimulated 
with Dunnett’s post hoc test, *P < 0.05, **P < 0.01, ***P < 0.001. Statistical analysis was 
performed using Graph Pad Prism. 
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Notes 
 
1. QUANTI-BlueTM signal can be detected between 15 min to 24 h after adding cell supernatant. 
Determine the optimal time point for measuring QUANTI-BlueTM signal to be able to compare 
between independent experiments.  
2. THP1-BlueTM NF-κB cells respond robustly to TLR1/2, TLR2/6, TLR4, TLR5, TLR8, NOD1 and 
NOD2 agonists. However, poor responses have been observed with TLR3, TLR7 and TLR9 
ligands.  
3. Robust SEAP signal can be detected from 8 h after cell stimulation with TLR4 ligands (Figure 
3). Nevertheless, it is recommended to titrate the stimulus of interest to determine the optimal 
dose and time point after stimulation to assess NF-κB activation. 
 
 
Figure 3. Time course of NF-κB activation in THP1-BlueTM NF-κB cells. Cells were 
stimulated with 1 ng/ml of LPS or 1 μM FBG-C and NF-κB activation was measured using 
QUANTI-BlueTM at different time points. Data shown as mean ± SEM, N = 3 independent 
experiments. One-way ANOVA vs. time 0 h with Dunnett’s post hoc test, *P < 0.05, **P < 0.01, 
***P < 0.001.  
 
4. THP1-BlueTM NF-κB cells should not be used after the 12th passage (Figure 4). According to the 
manufacturer (Invivogen), these cells undertake genotypic changes that result in reduced 
responsiveness over time under normal culture conditions. It is important to prepare frozen 
stocks at early passages. 
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Figure 4. Measurement of NF-κB activation in THP1-BlueTM NF-κB cells at different 
passages. Cells from different passages were stimulated with 0.5 ng/ml of LPS or left 
unstimulated (-) and NF-κB activation was measured after 24 h using QUANTI-BlueTM. Data 
shown as mean ± SEM, N = 3. Paired t-test vs. non-stimulated, *P < 0.05, **P < 0.01, ***P < 
0.001.  
 
5. THP1-BlueTM NF-κB cells cannot be used to assess cytokine protein expression. No cytokines 
can be reliably detected in the supernatant of these cells after activation with LPS (Figure 5). 
 
 
Figure 5. THP1-BlueTM NF-κB cells do not express cytokines. Cells were stimulated with 
different doses of LPS or left unstimulated (-) and NF-κB activation was measured after 24 h 
using QUANTI-BlueTM; or cytokine synthesis (IL-8, TNF and IL-6) was measured by ELISA. Data 
shown as mean ± SD, N = 2 independent experiments.  
 
6. When testing the inflammatory activity of recombinant proteins, the LPS content of preparations 
should be < 10 pg/ml. Additional controls that should be included are 1) incubation of the 
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recombinant protein with polymyxin B, an antibiotic that inhibits pathogenic activation of TLR4, 
but which doesn’t affect the recombinant protein activity; and 2) boiling the samples, which 
doesn’t affect LPS activity, but denatures the protein, destroying its pro-inflammatory activity 
(Figure 6). 
 
 
Figure 6. Effect of polymyxin B (PMB) and boiling on LPS and FBG-C activity in THP1-
BlueTM NF-κB cells. Cells were left unstimulated (-) or stimulated with LPS or FBG-C pre-
incubated with PMB for 30 min or boiled for 15 min. NF-κB activation was measured using 
QUANTI-BlueTM. Data shown as mean ± SEM, N = 4 independent experiments. Paired t-test vs. 
non-treated, ***P < 0.001.  
 
Recipes 
 
1. ThP1 media without blasticidin 
RPMI 1640 
10% FBS 
1% penicillin/streptomycin 
100 µg/ml NormocinTM 
2. ThP1 media with blasticidin 
RPMI 1640 
10% FBS 
1% penicillin/streptomycin 
10 µg/ml blasticidin 
100 µg/ml NormocinTM 
3. QUANTI-BlueTM solution 
One pouch of QUANTI-BlueTM  
100 ml of endotoxin-free water 
Pour the content of one pouch of QUANTI-BlueTM in a sterile flask with 100 ml of endotoxin-free 
water. Incubate QUANTI-BlueTM solution at 37 °C for 30 min and swirl gently every 10 min to 
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dissolve the powder. QUANTI-BlueTM solution is stable for 2 weeks at 2-8 °C, or two month at -
20 °C. Keep reconstituted QUANTI-BlueTM away from light  
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